This is a non-core endpoint: only basic statistics are computed.
Pregnant state, incidental
Z21_PREGNANT_STATE_INCIDENTAL
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
24 |
4. Check minimum number of eventsNone |
24 |
5. Include endpointsNone |
24 |
6. Filter based on genotype QC (FinnGen only) |
24 |
Control definitions (FinnGen only)
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z3
Similar endpoints
↥List of similar endpoints to
Pregnant state, incidental
based on the number of shared cases.
Similar with more cases:
- Persons encountering health services in circumstances related to reproduction
- Propionic acid derivatives
- Factors influencing health status and contact with health services
- Anti-inflammatory and antirheumatic products, non-steroids
- Paracetamol of NSAID medication
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 24 | 24 | - |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | - |
| Median age at first event (years) | 26.15 | 26.15 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026008) Bacteria identified in Urine by Culture
15
42
7.77
5.25
3.0
1.9
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
14
47
5.75
4.27
4.2
3.3
—
—
—
0
0
(3015736) pH of Urine
15
56
5.43
3.89
3.5
2.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
9
19
6.89
3.68
1.6
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
14
53
4.94
3.57
1.9
2.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
11
37
4.64
3.18
4.6
2.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
5
5
12.11
3.12
7.8
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
18
94
4.63
3.03
5.3
6.0
e9/l
0.0
0.0
0.00
13
78
(3026782) Osmolality of Urine
9
25
5.11
2.95
4.3
2.6
mosm/kgh2o
477.4
540.6
—
9
25
(3042936) Bacteria identified in Isolate by Culture
7
16
5.70
2.71
1.3
3.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
12
6.25
2.57
1.7
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
14
65
3.77
2.50
6.4
2.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
9
31
4.02
2.39
3.3
2.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
13
61
3.47
2.23
1.9
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
11
47
3.47
2.16
1.5
1.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
9
35
3.49
2.08
2.1
2.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
14
73
3.20
1.96
1.6
2.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
13
65
3.18
1.95
5.8
8.8
mmol/l
1.2
1.2
0.13
13
56
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
12
58
3.14
1.90
1.8
1.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
7
25
3.52
1.81
2.0
2.2
—
—
—
0
0
(3044889) 12 lead EKG panel
16
94
3.09
1.81
1.9
2.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
11
54
2.91
1.65
6.4
2.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
12
62
2.87
1.64
4.4
5.3
mmol/l
1.2
1.2
0.42
12
56
(3023368) Bacteria identified in Blood by Culture
7
28
3.10
1.60
3.1
2.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
12
64
2.75
1.52
2.1
1.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
18
120
2.99
1.52
7.0
3.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
5
16
3.66
1.52
1.8
1.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
5
18
3.22
1.36
2.0
1.8
s
28.4
30.2
—
5
18
(3019832) Treponema pallidum Ab [Presence] in Serum
9
46
2.52
1.22
1.6
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
70
2.43
1.21
2.7
2.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
21
2.73
1.15
4.0
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
5
22
2.59
1.09
1.6
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
24
210
+∞
1.06
13.7
7.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
8
43
2.28
1.01
3.1
9.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
12
75
2.20
0.99
2.1
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
9
53
2.11
0.90
2.2
1.9
mg/l
3.0
2.7
—
9
43
(46235355) HIV 1 and 2 tests - Meaningful Use set
12
84
1.86
0.66
2.0
1.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
9
61
1.76
0.64
4.6
4.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
0
22
0.00
0.62
0.0
4.3
—
25.8
—
0
13
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
10
67
1.84
0.62
6.4
3.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
5
80
0.53
0.59
2.4
1.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
7
45
1.78
0.56
1.7
1.6
—
—
—
0
0
(3019225) pH of Specimen
0
15
0.00
0.43
0.0
9.1
—
—
—
0
0
(4010399)
0
15
0.00
0.43
0.0
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
15
0.00
0.43
0.0
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
7
52
1.49
0.36
1.9
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
8
61
1.46
0.33
3.5
4.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
41
1.28
0.24
1.2
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
0
10
0.00
0.22
0.0
1.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
24
228
+∞
0.22
21.0
13.2
e9/l
7.7
6.9
1.37
24
222
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
0
12
0.00
0.22
0.0
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
24
226
+∞
0.20
21.1
13.3
e9/l
288.4
280.9
0.23
24
221
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
18
187
0.85
0.10
3.8
3.1
mmol/l
4.9
4.7
0.45
18
175
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
18
186
0.87
0.10
3.8
3.0
mmol/l
1.4
1.5
0.31
18
174
(3015377) Calcium [Moles/volume] in Serum or Plasma
5
60
0.79
0.09
2.6
3.8
mmol/l
2.3
2.3
—
5
53
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
19
182
1.21
0.09
5.9
3.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
13.5
—
0.6
—
0
6
(3002523) Influenza virus A Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
13.1
—
837.1
—
0
7
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
19
187
1.08
0.00
3.7
3.1
mmol/l
3.0
2.8
0.55
19
176
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
0
8
0.00
0.00
0.0
7.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
0
8
0.00
0.00
0.0
6.8
—
23.2
—
0
8
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
116.2
—
0
5
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
18
177
1.07
0.00
3.4
2.8
mmol/l
1.5
1.1
1.09
18
165
(3004616) Nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
5.6
—
0
8
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
8
0.00
0.00
0.0
1.4
—
12.6
—
0
8
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
14.1
—
1403.9
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_PREGNANT_STATE_INCIDENTAL – Pregnant state, incidental
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).